TY  - JOUR

T1  - A UK cost–effectiveness analysis of trifluridine/tipiracil for heavily pretreated metastatic gastroesophageal cancers

JO  - Future Oncology

UR  - http://dx.doi.org/10.2217/fon-2022-0662

PY  - 2023/04/28

AU  - Hamerton L

AU  - Gomes K

AU  - Fougeray R

AU  - Hook ES

AU  - Gomes MV

AU  - Hauch O

AU  - Bullement A

ED  - 

DO  - DOI: 10.2217/fon-2022-0662

PB  - Future Medicine Ltd

VL  - 19

IS  - 9

SP  - 643

EP  - 650

Y2  - 2024/12/26

ER  -